cyclosporine - Generic mfg.
Toctino (alitretinoin) - Basilea
Revisiting Palmoplantar Inflammatory Dermatoses (EADV-Sp 2026) - May 13, 2026 - Abstract #P0567; ID-574; "A retrospective outcomes study compared systemic therapy in refractory CHE, evaluating oral alitretinoin versus cyclosporine using 24-week response and drug survival. PPP similarly aligns with psoriasis-adjacent differentiation abnormalities while retaining distinctive clinicopathological features, whereas pompholyx and typical CHE more closely follow an eczematous differentiation pattern. Integrating IHC signatures with real-world systemic treatment outcomes provides a biologically grounded framework that may improve diagnostic precision and guide individualized systemic treatment selection in palmoplantar disease." 
Atopic Dermatitis • Contact Dermatitis • Dermatology • Immunology • Psoriasis
https://s3.eu-central-1.amazonaws.com/m-anage.com.storage.eadv/abstracts_symposium_2026/61951.pdf
 
Yeji Jang 1; Seongjun Kim1
 
May 13, 2026
 
Prev Next